Virbac SA (EPA:VIRP)
France · Delayed Price · Currency is EUR 353.50
-4.00 (-1.12%)
Jan 2, 2026, 5:35 PM CET
Virbac Market Cap
Virbac has a market cap or net worth of €3 billion as of January 2, 2026. Its market cap has increased by 14.63% in one year.
Market Cap
3.00B
Enterprise Value
3.18B
Revenue
1.43B
Ranking
n/a
PE Ratio
22.51
Stock Price
€353.50
Market Cap Chart
Since August 8, 1994, Virbac's market cap has increased from 217.52M to 3.00B, an increase of 1,276.92%. That is a compound annual growth rate of 8.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 3.00B | 13.00% |
| Dec 31, 2024 | 2.65B | -12.68% |
| Dec 29, 2023 | 3.04B | 57.52% |
| Dec 30, 2022 | 1.93B | -46.24% |
| Dec 31, 2021 | 3.58B | 78.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 124.46B |
| Sanofi | 100.65B |
| Sartorius Stedim Biotech | 20.43B |
| bioMérieux | 13.02B |
| Eurofins Scientific SE | 11.04B |
| Ipsen | 9.77B |
| ABIVAX Société Anonyme | 9.37B |
| emeis Société anonyme | 2.31B |